The current situation of the COVID-19 epidemy is so exceptional and particular.

Clinical testing laboratories anywhere in the world are adapting their organization to meet customer expectations, preserve the health of their employees and volunteers and, above all, minimize the risk of spread. Some of the CRO’s open their center in China.

In-vitro or ex-vivo testing laboratories are also organized to comply with these safety and hygiene measures and to manage ongoing studies.

During this special period, the Skinobs team continues its collaborative mission of sharing expertise related to cosmetic testing:

• The newsfeed continues its weekly publication in French or English,
• The articles in the news feed remain online permanently,
• The Newsletter, Zoom 15 will soon be send to you.

We continue, as usual, our work to update the “CLINICAL” platform, dedicated to clinical trials and continuously optimize its functionality. You’ll find more than 280 methods and details of testing services for more than 80 CRO’s.

The new “PRECLINICAL” platform dedicated to analytical, ex-vivo and in-vitro testing is almost ready, the beta version is being tested. And we’ll launch it in April. You will find your testing partners for : stability, microbiology, cutaneous penetration, ecotoxicity, biodegradability, safety and efficacy…

We will do our utmost to continue sharing via Skinobs News or Linkedin and communicate the know-how of a sector that scientifically accompanies each product development; to support your projects and prepare for the future effectively.

During this special period, we remain available for any questions about testing or updating your information on these two platforms and Newsfeed.

We wish you all to live this period with solidarity and serenity. Take care.

Anne Charpentier

acharpentier@skinobs.com